- Joined
- Jan 15, 2008
- Messages
- 72
A two-year study of how well glucosamine and chondroitin sulfate slows cartilage loss in patients with arthritis could not show that the popular nutritional supplements worked any better than sugar pills. Geez, I hope Bob Wilson doesn’t read this post cause he swears by the stuff!
“We don’t have good evidence that it slows (disease) progression,” says rheumatologist Allen Sawitzke, professor of internal medicine at the University of Utah and lead investigator.
Glucosamine & Chondroitin
The combination glucosamine chondroitin is very popular amongst bodybuilders and competitive powerlifters and is the sixth-top-selling supplement in the US, with annual sales of $831 million in 2007. This study is a follow-up to a 2006 study that looked at whether the supplements did a better job than sugar pills or the arthritis pain medication Celebrex in diminishing pain in patients with osteoarthritis. Researchers continued to give patients the supplements, sugar pills or Celebrex, and measured whether the space between their knee joints decreased (a measure of whether the cartilage was breaking down). The two-year study didn’t show that anything worked better than the placebo to slow the progress of the disease.
“We don’t have good evidence that it slows (disease) progression,” says rheumatologist Allen Sawitzke, professor of internal medicine at the University of Utah and lead investigator.
Glucosamine & Chondroitin
The combination glucosamine chondroitin is very popular amongst bodybuilders and competitive powerlifters and is the sixth-top-selling supplement in the US, with annual sales of $831 million in 2007. This study is a follow-up to a 2006 study that looked at whether the supplements did a better job than sugar pills or the arthritis pain medication Celebrex in diminishing pain in patients with osteoarthritis. Researchers continued to give patients the supplements, sugar pills or Celebrex, and measured whether the space between their knee joints decreased (a measure of whether the cartilage was breaking down). The two-year study didn’t show that anything worked better than the placebo to slow the progress of the disease.